This website has been developed by ALK and is intended for healthcare professionals only. Jext® is indicated in the emergency treatment of severe acute allergic reactions (anaphylaxis) to insect stings or bites, foods, drugs and other allergens as well as idiopathic or exercise induced anaphylaxis. Prescribing Information UK ROI

Contact Us
Expiry Alert Service

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (for the United Kingdom) or www.hpra.ie (for Republic of Ireland).

Adverse events should also be reported to ALK-Abelló Ltd. Email: [email protected] Phone: +44(0)118 903 7940

Terms of Use
This site provides additional patient information to ONLY those patients who are currently prescribed Jext®. Any information contained in this site should not be acted upon without first consulting your doctor. Jext® is a registered trademark of ALK-Abelló Ltd.

Click below for:

Jext 150mcg SPC
UK ROI
Jext 300mcg SPC
UK ROI
Patient Information Leaflet
UK ROI

ALK-Abelló Ltd, 1 Manor Park,
Manor Farm Road,
Reading, Berkshire,
RG2 0NA

Tel: +44(0)118 903 7940

Email: [email protected]

© Copyright 2025 ALK-Abelló LtdContact usDisclaimerPrivacy NoticeExpiry Alert Cancellation

January 2025
IE-JXT-2400021